https://www.selleckchem.com/pr....oducts/trastuzumab.h
This work provides an effective method for the development of highly efficient perovskite oxide catalysts.Protein kinase inhibitors disrupt phosphorylation of the target kinases, which are an important class of drug for treating cancer and other diseases. Conventional structure-based design methods (such as molecular docking) focus on the static binding mode of the kinase inhibitor with its target. However, dissociation kinetic properties of a drug molecule are found to correlate with its residence time in vivo and thus have drawn t
Like
Comment
Share
